近期，无锡市第九人民医院、无锡市骨科医院成功开展江苏省首例"Kai"显微手术机器人辅助下皮瓣血管吻合术，显微外科机器人搭载2毫米七自由度仿生 机械臂实现超微血管缝合。此次手术的成功，不仅标志着无锡九院在显微外科精准治疗领域迈入"机器人辅助"新时代，更以实际疗效印证了江苏省骨科区 域医疗中心(建设单位)的技术引领力。 省级区域医疗中心推动前沿技术落地惠民 "这台手术的成功，不仅是技术的突破，更是'以患者为中心'的实践。"无锡九院党委书记芮永军表示，作为江苏省骨科区域医疗中心(建设单位)，医院始 终致力于将前沿医疗技术转化为临床疗效，让患者在家门口就能享受到高水平诊疗服务。 工伤致肢体重创高难度修复遇挑战 冉先生是一名工厂工人，因机器压伤致右腕大面积皮肤缺损、出血明显，赶往无锡九院急诊就诊。急诊诊断为右腕部正中神经、尺神经、尺动脉、屈肌腱 损伤、断裂，右开放性桡腕关节骨折脱位，病情危急，面临手部活动功能丧失风险。 核心操作阶段，"Kai"显微手术机器人展现出强大优势：其搭载的2毫米七自由度仿生机械臂，可通过3D高清外视镜将手术视野放大20倍，配合智能动态 消颤技术，将操作精度控制在3-5微米；同时，机器人能实时监 ...

Core Viewpoint - The surgical robot market in China is experiencing significant growth, with a 82.9% year-on-year increase in the number of surgical robots awarded contracts in the first five months of 2025, despite some companies facing bankruptcy and liquidation [1] Group 1: Market Dynamics - The surgical robot industry is highly competitive, with numerous domestic companies participating in various segments, including over 16 approved laparoscopic surgical robots and more than 50 orthopedic surgical robots [1] - The number and amount of financing in the surgical robot sector have sharply decreased, leading to potential funding crises for companies that have not yet achieved commercial revenue [1][3] - The market is witnessing a price war among companies, with various surgical robots being commercialized at significantly different price points, yet the market leader, the Da Vinci surgical robot, remains unaffected in terms of sales [4][5] Group 2: Clinical and Technological Challenges - Some surgical robots are limited to simple procedures, and their clinical value has not yet been fully realized, as evidenced by a study showing that 11% of robot-assisted coronary interventions required conversion to manual operation [2][4] - The commercial success of surgical robots is heavily influenced by policies and macroeconomic conditions, with some companies experiencing significant declines in sales and revenue due to factors like anti-corruption measures and slowed bidding processes [5] Group 3: Innovations and Strategies - Companies are focusing on technological innovations, including the integration of AI to enhance the capabilities of surgical robots, with several firms already developing AI-enabled products [8][9] - Efforts are being made to reduce product costs to make surgical robots more accessible to hospitals, such as the modular design of the HaiShan laparoscopic surgical robot [9] - Companies are exploring remote surgical technologies to expand their market reach and improve access to quality healthcare, with several firms successfully conducting remote surgeries [9][10] Group 4: Market Expansion and Accessibility - Surgical robot companies are increasingly looking to international markets for growth, with firms like MicroPort achieving significant revenue increases through overseas orders [12] - There is a trend of surgical robots being adopted in county-level hospitals, which allows for more complex procedures to be performed locally, thus improving healthcare access for patients [14][15]